Johanna Ivaska

We are very proud to announce @johannaivaska as recipient of the Biennial Finnish Science Award. Johanna was described as a distinguished researcher with pioneering work in cell biology. Warmest congrats from all of us, boss! utu.fi/en/news/news/f…

Yesterday my student Matilda Roos-Mattila defended her thesis on ”Stromal Inflammatory Markers and Drug Sensitivities in Pancreatic Malignancies” with potential help for PDAC patients (stay tuned). Prestige opponent prof Johanna Ivaska ⁦@johannaivaska⁩

🚨 Exciting News! As we count down to #CellMech2025, we’re highlighting our incredible keynote speakers! 🌟 (1/2) 🧫🔬 @johannaivaska leads the Cell Adhesion & Cancer Lab, focusing on integrins, mechanosensing, and their role in cancer progression.

(2/2) Her research aims to uncover how cellular interactions influence disease outcomes. Don’t miss her talk at #CellMech2025! 🔬 Stay tuned for more speaker profiles! 📅 #CellMech2025

K. Albin Johansson -tutkijaprofessorimme ⁦@johannaivaska⁩ painottaa lääketutkimusten ja uusien syöpälääkkeiden arvoa. ⁦@IvaskaLab⁩ tutkii terveitä soluja syöpäsolujen ympärillä ymmärtääkseen, miten kudos voi hillitä syövän kehittymistä. hs.fi/alueet/art-200…

”Lääketutkimukset ja niiden perusteella kehitetyt kalliit syöpähoidot ja täsmälääkkeet ovat korvaamattoman tärkeitä nyt ja tulevaisuudessa.” ⁦@Laaketeollisuus⁩ Kannattaa lukea kv. syöpätutkijan näkemys 👇🏻 ⁦@hsfi⁩ | ⁦@johannaivaska⁩ hs.fi/alueet/art-200…

”Kukaan ei koskaan pysty suojaamaan itseään syövältä täysin, vaikka eläisi miten. Mutta omaa riskiä sairastua voi pienentää terveellisillä elämäntavoilla.” ⁦@johannaivaska⁩ ⁦@UniTurku⁩ Tarvitsemme Suomessa korkealaatuista syöpätutkimusta. hs.fi/alueet/art-200…

The most recent preprint from our most recent PhD graduate Dr Nicolas Pasquier. Orientation of mucinous CRC apicobasal polarity is regulated by tumor-stroma interactions. This work was a collaboration with @JaulinLab at the Gustave Roussy Institute. biorxiv.org/content/10.110…

Excited to share some of my PhD findings! Go check out how A/B polarity orientation is controlled in CRC metastasis @IvaskaLab @JaulinLab ▶️ biorxiv.org/cgi/content/sh…

Jasmin from @IvaskaLab will defend her thesis this Friday!

I am moving now to @johannaivaska.bsky.social @bluesky 🦋!! I will keep this handle active for a while during this transition, although all the fun science updates will soon only be 'there' :) Looking forward to re-connecting with everyone

Super excited and proud to see this amazing work coming out. Years of hard-work paying off! Big thanks to @guijacquemet and @Follain_Ga for providing an opportunity to work on such an amazing project!

Super excited about this amazing collaboration with @IvaskaLab @guijacquemet @SalmiLab and the cellmig.org lab biorxiv.org/content/10.110… Identifying details of cancer cell and leukocyte adhesion to endothelial monolayer under flow

After the great success of Adhere1 last September, @ambriovic, @KostourouVasso and myself are excited to announce that Adhere2 will go ahead next September. 3rd-6th September 2025 in beautiful Zadar, Croatia.

Latest from Ivaska Lab▶️ @johannalilja_, Kaivola et al. report an unanticipated way to kill KRAS mutant cancer cells by disrupting SHANK3-KRAS interaction 👌😎 Congratulations to all the authors and check the paper out here 👉rdcu.be/dTQDP

Excited to share our latest paper by @johannalilja_ , #JasminKaivola, @johannaivaska et al., on the role of SHANK3-KRAS interaction in targeting KRAS-mutant cancers is out in @NatureComms. Grateful to have been a part of this! Congrats to all! rdcu.be/dTQDP

Don't miss this seminal review by the one and only @NabaLabUIC!!! A must read! #ECM @MetastasisRS

Check out @IvaskaLab latest unexpected discovery on hyperactivation as a way to kill KRAS mutant cancer cells and limit KRASmut xenograft growth with nanobodies disrupting SHANK3-KRAS interaction 👇

What happens when unexpected happens!? 1) @johannalilja_ @IvaskaLab #JasminKaivola identified SHANK3 as a KRAS inhibitor 2) predicted SHANK3 depletion boosts KRASmut tumors 3) observed SHANK3 depletion kills KRAS-cells by ERK hyperactivation, apoptosis rdcu.be/dTQDP